Various Pharmaceutical Items
Award Notice Posted
- Solicitation number
- VA-797-10-RP-0028
- Agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Awarded
- to Mylan Pharmaceuticals Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- VA797P0206 Federal IDV award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- Not on record
Notice details come from SAM.gov. Updated .
Notice text
2 versions
Update #2 · Latest ·
Added: Jan 20, 2010 8:06 am
Modified: Jan 20, 2010 11:41 amTrack Changes
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) VA-797-10-RP-0028 under competitive negotiated procedures for numerous pharmaceutical items. Please see Attachment "A" for the list of the items and estimated annual usage. The estimated annual usage includes VA, DoD, Indian Health Service (IHS), and Bureau of Prisons (BOP). The contract period will be for one year plus four pre-priced option periods. The contract items will be distributed through VA's and DoD's respective Pharmaceutical Prime Vendors.
This procurement is subject to the requirements of the Trade Agreements Act, *except that offers from countries not covered by any Free Trade Agreement will be considered if, and only if, no offers are received from U.S. made or from Trade Agreement designated countries pursuant to Federal Acquisition Regulation Part 25.403(c) and/or the items being procured are not on a government-wide contract. Each solicitation line item will represent separate requirements for the purpose of Federal Acquisition Regulation Clause 52.217-9, "Option to Extend the Term of the Contract" and FAR Clause 52.233-3, "Service of Protest." A separate determination on the exercise of subsequent contract options will be made individually per solicitation line item awarded.
Products offered must be FDA compliant. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and products proposed must have unique NDC numbers. Capsules must be compatible with automated dispensing units (Baxter ATC Canisters, Optifil, etc.). If the offeror is not a manufacturer, a signed agreement between the offeror and the manufacturer must be submitted with the offer.. Solicitation No VA-797-10-RP-0028 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about February 3, 2010, with an estimated closing date of February 24, 2010. The NAICS code for this procurement is 325412 and *Numbered Note 12 applies. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: http://www.fedbizopps.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is James Wenzbauer. Questions can be e-mailed to: james.wenzbauer2@va.gov
ATTACHMENT A
DESCRIPTION Total Estimated Annual Usage
ACETIC ACID 2% HYDROCORTASONE 1% OTIC 10ML 18,669
ALBUTEROL 2MG TAB 100 4,335
ALBUTEROL 4MG TAB 100 7,662
ANAGRELIDE 0.5MG 100 7,303
ANAGRELIDE 1MG 100 1,245
BACITRACIN OPTH OINT 1/8 OZ 61,562
CHLORDIAZEPOXIDE 10MG CAP 100 13,641
CHLORDIAZEPOXIDE 25MG CAP 100 8,471
CHLORDIAZEPOXIDE 5MG CAP 100 4,265
CLOBETASOL PROPIONATE 0.05% OINTMENT 15GM 29,305
CLOBETASOL PROPIONATE 0.05% OINTMENT 30GM 127,541
CLOBETASOL PROPIONATE 0.05% OINTMENT 45GM 28,308
CLOBETASOL PROPIONATE 0.05% OINTMENT 60GM 16,511
CLOBETASOL PROPIONATE 0.05% CREAM 15GM 29,481
CLOBETASOL PROPIONATE 0.05% CREAM 30GM 84,912
CLOBETASOL PROPIONATE 0.05% CREAM 45GM 9,105
CLOBETASOL PROPIONATE 0.05% CREAM 60GM 17,264
CLOMIPRAMINE HCL 50MG CAP 100 4,823
DILTIAZEM HCL 120MG TAB 100 5,644
DILTIAZEM HCL 30MG TAB 100 6,017
DILTIAZEM HCL 30MG TAB 500 2,717
DILTIAZEM HCL 60MG TAB 100 10,944
DILTIAZEM HCL 60MG TAB 500 3,145
DILTIAZEM HCL 90MG TAB 100 9,080
ATROPINE SO4 0.025MG/DIPHENOXYLATE HCL 2.5MG TAB 100 53,548
DISOPYRAMIDE CAP 100MG 100 1,948
DISOPYRAMIDE CAP 150MG 100 2,789
ESTRADIOL TAB 0.5MG 100 7,872
ESTRADIOL TAB 1MG 100 10,845
ESTRADIOL TAB 2MG 100 4,600
FAMOTIDINE 20MG UU 100 6,369
FAMOTIDINE 40MG UU 100 6,584
GLYBURIDE MICRONIZED TAB 1.5MG 100 2,929
GLYBURIDE MICRONIZED TAB 3MG 100 20,977
GLYBURIDE MICRONIZED TAB 6MG 100 10,500
NADOLOL 20MG TAB 100 5,843
NADOLOL 40MG TAB 100 8,266
NADOLOL 80MG TAB 100 2,594
PHENAZOPYRIDINE HCL 100MG TAB 100 27,307
PHENAZOPYRIDINE HCL 200MG TAB 100 5,398
PROCHLORPERAZINE TAB 10MG 100 25,902
PROCHLORPERAZINE TAB 5MG 100 16,539
SPIRONOLACTONE/HCTZ 25-25 TAB 100 3,934
SPIRONOLACTONE/HCTZ 25-25 TAB 500 836
THIOTHIXENE HCL 10MG CAP 100 4,746
THIOTHIXENE HCL 2MG CAP 100 2,583
THIOTHIXENE HCL 5MG CAP 100 4,782
ZALEPLON 10MG CAP 100 6,360
ZALEPLON 5MG CAP 100 1,294
VERAPAMIL HCL 80MG TAB 100 7,067
VERAPAMIL HCL 80MG TAB 500 1,974
or or
VERAPAMIL HCL 80MG TAB 1000 987
VERAPAMIL HCL 120MG TAB 100 8,474
VERAPAMIL HCL 120MG TAB 500 1,968
or or
VERAPAMIL HCL 120MG TAB 1000 984
VERAPAMIL HCL 40MG TAB 100 1,828
BUMETANIDE 0.5MG TAB 100 5,674
BUMETANIDE 1MG TAB 500 7,412
OR
BUMETANIDE 1MG TAB 1000 3,706
BUMETANIDE 2MG TAB 500 4,192
OR
BUMETANIDE 2MG TAB 1000 2,096
CAFFEINE 100MG/ERGOTAMINE TARTRATE 1MG TAB 100 6,433
DANAZOL 100MG CAP 100 272
DANAZOL 200MG CAP 100 1,164
DANAZOL 50MG CAP 100 223
DOXEPIN HCL 150MG CAP 100 1,463
MEXILETINE HCL 150MG CAP 100 6,638
MEXILETINE HCL 200MG CAP 100 3,847
MEXILETINE HCL 250MG CAP 100 436
NEFAZODONE 100MG TAB 60 8,418
NEFAZODONE 150MG TAB 60 9,848
NEFAZODONE 200MG TAB 60 16,232
NEFAZODONE 250MG TAB 60 1,545
NEFAZODONE 50MG TAB 100 381
PROPYLTHIOURACIL 50MG TAB 100 13,104
TOLMETIN NA 200MG TAB 100 610
Update #1 ·
Added: Jan 20, 2010 8:06 am
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) VA-797-10-RP-0028 under competitive negotiated procedures for numerous pharmaceutical items. Please see Attachment "A" for the list of the items and estimated annual usage. The estimated annual usage includes VA, DoD, Indian Health Service (IHS), and Bureau of Prisons (BOP). The contract period will be for one year plus four pre-priced option periods. The contract items will be distributed through VA's and DoD's respective Pharmaceutical Prime Vendors.
This procurement is subject to the requirements of the Trade Agreements Act, *except that offers from countries not covered by any Free Trade Agreement will be considered if, and only if, no offers are received from U.S. made or from Trade Agreement designated countries pursuant to Federal Acquisition Regulation Part 25.403(c) and/or the items being procured are not on a government-wide contract. Each solicitation line item will represent separate requirements for the purpose of Federal Acquisition Regulation Clause 52.217-9, "Option to Extend the Term of the Contract" and FAR Clause 52.233-3, "Service of Protest." A separate determination on the exercise of subsequent contract options will be made individually per solicitation line item awarded.
Products offered must be FDA compliant. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and products proposed must have unique NDC numbers. Capsules must be compatible with automated dispensing units (Baxter ATC Canisters, Optifil, etc.). If the offeror is not a manufacturer, a signed agreement between the offeror and the manufacturer must be submitted with the offer.. Solicitation No VA-797-10-RP-0028 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about February 3, 2010, with an estimated closing date of February 24, 2010. The NAICS code for this procurement is 325412 and *Numbered Note 12 applies. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: http://www.fedbizopps.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is James Wenzbauer. Questions can be e-mailed to: james.wenzbauer2@va.gov
Files
| File | Type | Posted |
|---|---|---|
| VA-797-10-RP-0028-0001000.DOC | DOC document | |
| VA-797-10-RP-0028-000.DOC | DOC document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Verapamil Tablets | Award Notice | |
| This notice | Award Notice |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity